第一单位：
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia.
作者：
R V,Rawson [1]
;
N G,Maher [2]
;
A M,Menzies [3]
;
S N,Lo [4]
;
N,Mesbah Ardakani [5]
;
L A,Jackett [6]
;
I A,Vergara [4]
;
T E,Pennington [7]
;
K F,Shannon [7]
;
S,Ch'ng [7]
;
M,Gonzalez [8]
;
E M,Burton [9]
;
M W,Lucas [10]
;
I L M,Reijers [10]
;
E A,Rozeman [10]
;
D E,Gyorki [11]
;
S,Sandhu [6]
;
M S,Carlino [12]
;
J,Howle [13]
;
M,Khattak [14]
;
A,Van der Westhuizen [15]
;
M C,Andrews [16]
;
V,Atkinson [17]
;
A C J,van Akkooi [18]
;
A J,Spillane [3]
;
R P M,Saw [7]
;
B A,van de Wiel [10]
;
C U,Blank [10]
;
G V,Long [19]
;
M T,Tetzlaff [20]
;
R A,Scolyer [21]
作者单位：
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia.
[1]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
[2]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia.
[3]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia.
[4]
Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, Australia.
[5]
Peter MacCallum Cancer Centre, Melbourne, Australia.
[6]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia.
[7]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
[8]
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
[9]
The Netherlands Cancer Institute, Amsterdam, The Netherlands.
[10]
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
[11]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Westmead Hospital, Sydney, Australia; Blacktown Hospital, Sydney, Australia.
[12]
Westmead Hospital, Sydney, Australia.
[13]
Fiona Stanley Hospital, Edith Cowan University, Perth, Australia.
[14]
Lake Macquarie Oncology, Lake Macquarie Private Hospital, The Department of Medicine, University of Newcastle, Newcastle, Australia.
[15]
Department of Medical Oncology, Alfred Health, Melbourne, Australia; Department of Medicine, School of Translational Medicine, Monash University, Melbourne, Australia.
[16]
Princess Alexandra Hospital, University of Queensland, Brisbane, Australia.
[17]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia.
[18]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore, Sydney, Australia; The Mater Hospital, Wollstonecraft, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia.
[19]
Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California, San Francisco, USA. Electronic address: michael.tetzlaff@ucsf.edu.
[20]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: Richard.Scolyer@health.nsw.gov.au.
[21]
DOI
10.1016/j.annonc.2025.10.1237
PMID
41183783
发布时间
2026-01-21
换一批
